Free Trial

Rapport Therapeutics (RAPP) News Today

Rapport Therapeutics logo
$14.39 +0.01 (+0.07%)
As of 09:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RAPP Latest News

Breakthroughs Backed by Wall Street - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
Analysts Can't Get Enough of These Little-Known Biopharma Stocks (RAPP)
Three relatively unknown biopharma firms receive near-unanimous approval from analysts for their promising drug candidates in development.
Mise à disposition du rapport financier annuel 2024
Rapport Therapeutics initiated with an Outperform at Citizens JMP
Rapport Therapeutics: Too Early To Be Interesting
Rapport Therapeutics to present data at 2025 AAN meeting
Rapport Therapeutics sees cash runway through 2026
Get Rapport Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAPP and its competitors with MarketBeat's FREE daily newsletter.

RAPP Media Mentions By Week

RAPP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RAPP
News Sentiment

0.62

0.97

Average
Medical
News Sentiment

RAPP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RAPP Articles
This Week

3

2

RAPP Articles
Average Week

Get Rapport Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAPP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RAPP) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners